Strong sales at Teva's API division
Teva's sales of active pharmaceutical ingredients (APIs) for the first quarter of 2008 rose by 51 per cent on the previous years figure, taking to total to $510m.
Archives for May 6, 2008
China's preclinical services scene evolving outwards
China's preclinical services providers are beginning to carve a niche for themselves on the global stage, buoyed by the growth of the domestic market.
Bioprocessing holds back Millipore in Q1
Continued weakness in the market for products used in the manufacture of biologic drugs was the main reason why Millipore experienced a 'challenging' quarter, according to CEO Martin Madaus.
Parexel, Kendle, Quintiles, Encorium Group, Icon and Aesica - People on the move
Parexel, Kendle, Quintiles, Encorium Group, Icon and Aesica have all had people on the move in the world of pharmaceutical outsourcing.
Pfizer to build 190m Irish biologics plant
Pfizer's plans for a new €190m manufacturing plant in Shanbally, Ireland suggest that the firm is intent on fulfilling its pledge to become a "top five biologics producer in the next eight years."
Device to 'revolutionise' inhaled drug testing
UK-based Cambridge Consultants has developed a portable instrument which it says could "revolutionise" the way airborne drug delivery devices are tested.